Prevention of mother-to-child transmission: latest news

Prevention of mother-to-child transmission resources

Prevention of mother-to-child transmission features

Prevention of mother-to-child transmission in your own words

Prevention of mother-to-child transmission news from aidsmap

More news

Prevention of mother-to-child transmission news selected from other sources

  • The Best Antiretroviral Therapy for Pregnant Women? The Controversy Continues

    There's considerable controversy in an area of HIV medicine that one would think should be all but solved by now. It's what HIV treatment we should give pregnant women.

    18 October 2017 | The Body PRO
  • Breast-feeding by Women With HIV Disputed

    A controversy being debated around the world — whether women living with HIV should breast-feed — was in the spotlight here at the American Academy of Pediatrics 2017 National Conference and Exhibition.

    25 September 2017 | Medscape (free registration required)
  • BHIVA response to BMJ article on ART in pregnant women living with HIV

    We do not support recommendations of "ART in pregnant women living with HIV: a clinical practice guideline" (BMJ, 11/9/17). Other systematic reviews and numerous observational studies show tenofovir to be safe in HIV in pregnancy.

    25 September 2017 | BHIVA
  • Alice Welbourn: WHO and the rights of women living with HIV

    A recent set of articles on HIV in pregnancy, published by The BMJ and BMJ Open, raises concerns that some combination anti-retroviral therapies (cARTs) may harm babies. This highlights the need for changes to current WHO practice towards pregnant women living with HIV, which is no doubt well-intentioned but ill thought-out.

    12 September 2017 | BMJ Opinion
  • New recommendations aim to help pregnant women with HIV make informed choices

    New recommendations on antiretroviral drugs for pregnant women living with HIV can help women make more informed choices about benefits and harms, say a panel of international experts in The BMJ today. The panel recommend older drug combinations instead of the most widely used regimens to help reduce the risk of premature birth and neonatal death - which almost all women said they were extremely keen to avoid.

    12 September 2017 | EurekAlert
  • Vertical HIV transmission may be influenced by complex synergies with other STI – such as Cytomegalovirus

    The apparently greater susceptibility of sub-Saharan African women to HIV infection has led researchers to consider the various potential synergies between HIV and other genital infections or conditions of the vaginal microbiome. A recent study brings this wider perspective to bear on mother-to-child transmission, casting some fresh light on the complex interrelation between the ‘vertical’ transmission of HIV and active and Cytomegalovirus (CMV) viruria.

    27 July 2017 | BMJ Group blogs
  • Malawi: Study finds fear drives pregnant women with HIV from prevention services

    Our study investigated why HIV-positive pregnant women might drop out of an Option B+ treatment program. For many, the answer was fear. Fear of HIV disclosure, fear of stigma, fear of their husband’s reaction, risk of divorce and loss of economic support, along with a lack of social support, lack of self-efficacy and agency for women in the culture, and a lack of male involvement in the program generally.

    26 June 2017 | Science Speaks
  • Meds May Impact Prenatal Screening in HIV+ Patients

    Pregnant women with HIV taking integrase inhibitors at the time of their non-invasive prenatal screening test had a lower mean fetal fraction than those who were not taking the medication, a small study found here.

    08 June 2017 | MedPage Today HIV/AIDS
  • The living legacy of the Global Plan: eliminating HIV in children

    The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

    20 April 2017 | UNAIDS
  • The U.S. Should Continue Its Fight against AIDS in Children

    PEPFAR is a standout example of how to achieve great things through strategic U.S. foreign-assistance investments — and of how public–private partnerships can wed the efficiencies of the private sector with the scale and reach of the public sector. By maintaining the program’s funding — something we both advocate — the United States and this administration will be well positioned to celebrate a historic public-health achievement: the end of the AIDS epidemic for an entire generation of children.

    10 April 2017 | National Review
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.